LATITUDE study: PSA response characteristics and correlation with overall survival (OS) and radiological progression-free survival (rPFS) in patients with metastatic hormone-sensitive prostate cancer (mHSPC) receiving ADT plus abiraterone acetate and prednisone (AAP) or placebo (PBO)

Yazar
Tran, N.
Ozguroglu, M.
Sulur, G.
Protheroe, A.
Li, S.
Mundle, S. D.
Chi, K. N.
Rodriguez Antolin, A.
Feyerabend, S.
Fein, L.
Alekseev, B. Y.
De Porre, P.
Matsubara, N.
Fazazi, K.
Üst veri
Tüm öğe kaydını göster
Bağlantı
http://hdl.handle.net/20.500.12627/122369
Koleksiyonlar